![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61P 3/10 | |
A61K 38/20 |
(11) | Number of the document | 2683395 |
(13) | Kind of document | T |
(96) | European patent application number | 12708029.9 |
Date of filing the European patent application | 2012-03-09 | |
(97) | Date of publication of the European application | 2014-01-15 |
(45) | Date of publication and mention of the grant of the patent | 2018-08-01 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2012/054174 |
Date | 2012-03-09 |
(87) | Number | WO 2012/123381 |
Date | 2012-09-20 |
(30) | Number | Date | Country code |
11305269 | 2011-03-11 | EP | |
201161451663 P | 2011-03-11 | US |
(72) |
KLATZMANN, David, FR
SAADOUN, David, FR
CACOUB, Patrice, FR
ROSENZWAJG, Michčle, FR
PIAGGIO, Eliane, FR
BENSIMON, Gilbert, FR
BERNARD, Claude, FR
|
(73) |
INSERM (Institut National de la Santé et de la Recherche Médicale),
101, rue de Tolbiac, 75654 Paris Cedex 13,
FR
Assistance Publique - Hōpitaux de Paris, 3 Avenue Victoria, 75004 Paris, FR Sorbonne Université, 21, rue de l`Ecole de Médecine, 75006 Paris, FR |
(54) | USE OF LOW DOSE IL-2 FOR TREATING TYPE 1 DIABETES |
USE OF LOW DOSE IL-2 FOR TREATING TYPE 1 DIABETES |